European CDMO Leader Aenova positions as a leading European contract development and manufacturing organization with a strong multimodal offering across development to commercial production, presenting an opportunity to target regional pharmaceutical and dietary supplement clients seeking integrated CDMO services.

Expansion and Capacity Recent investments in new technologies and capacity, including a state-of-the-art spray drying platform and Killorglin facility expansion for amorphous solid dispersions and inhalation powders, signaling capacity for high-demand or complex formulations and potential upsell to customers needing advanced manufacturing capabilities.

Leadership Appointments New leadership hires such as Managing Director for Latina site and a Group COO indicate strategic focus and potential for improved operational reliability and customer engagement in key regions, enabling BD teams to approach clients with confidence in governance and execution.

Sustainability Momentum Award-winning sustainability efforts, including a Gold accreditation at CPHI Frankfurt 2025, can be leveraged to attract health-focused brands and EU-backed sustainability programs, opening cross-sell opportunities to clients prioritizing green manufacturing and compliant supply chains.

Innovation and Delivery Recognition as an Innovative Product Provider and ongoing development of innovative drug delivery systems present a value proposition for customers seeking differentiated formulations, enabling sales conversations around novel delivery technologies, faster time-to-market, and regulatory readiness.